Covaxin approval after due analysis of knowledge: Harsh Vardhan to Chhattisgarh

Union Health Minister Dr Harsh Vardhan Thursday informed the Chhattisgarh authorities that the drug regulator has granted permission to fabricate the Bharat Biotech’s Covaxin based mostly on the “prescribed procedure” and “after due evaluation of pre-clinical and clinical trial data”.
The Union minister wrote to the Chhattisgarh Health Minister that each Covaxin and Serum Institute’s Covishield vaccines are “safe and immunogenic” and “should be used expeditiously” to “rapidly confer protection to prioritized beneficiaries”.
The letter got here after the state authorities expressed considerations concerning provides of Covaxin citing “unavailability of phase 3 data and also lack of display of expiry date on the vial”. “Your concern regarding the unavailability of expiry date on Covaxin vial is also completely unfounded and without basis, as the same is mentioned on the label of vaccine vials,” Vardhan wrote.

Vardhan highlighted that the state has already achieved 69.87 per cent protection of its healthcare employees. “…You would appreciate that this coverage needs to improve significantly since the adequate quantity of both the vaccines are available with the state,” he mentioned. “…Both these vaccines being supplied to states are safe and immunogenic and should be used expeditiously to rapidly confer protection to prioritised beneficiaries thereby mitigation the impact of the pandemic at the earliest,” Vardhan wrote.